Table 5.
Conditional transition probabilities across lower and higher levels of LMX.
| Transition path | LMX | Difference | |
|---|---|---|---|
| Low | High | ||
| Low PsyCap (no transition) | 0.79** | 0.93** | n.s. |
| Low PsyCap ➛ Dominant efficacy PsyCap | 0.00 | 0.00 | n.s. |
| Low PsyCap ➛ Dominant hope PsyCap | 0.00 | 0.00 | n.s. |
| Low PsyCap ➛ Moderate high PsyCap | 0.09 | 0.01 | n.s. |
| Low PsyCap ➛ High PsyCap | 0.11 | 0.05 | n.s. |
| Dominant efficacy PsyCap ➛ Low PsyCap | 0.00 | 1.00** | <0.001 |
| Dominant efficacy PsyCap (no transition) | 1.00** | 0.00 | <0.001 |
| Dominant efficacy PsyCap ➛ Dominant hope PsyCap | 0.00 | 0.00 | n.s. |
| Dominant efficacy PsyCap ➛ Moderate high PsyCap | 0.00 | 0.00 | n.s. |
| Dominant efficacy PsyCap ➛ High PsyCap | 0.00 | 0.00 | n.s. |
| Dominant hope PsyCap ➛ Low PsyCap | 0.00 | 1.00** | <0.001 |
| Dominant hope PsyCap ➛ Dominant efficacy PsyCap | 0.00 | 0.00 | n.s. |
| Dominant hope PsyCap (no transition) | 0.93** | 0.00 | <0.001 |
| Dominant hope PsyCap ➛ Moderate high PsyCap | 0.07 | 0.00 | n.s. |
| Dominant hope PsyCap ➛ High PsyCap | 0.00 | 0.00 | n.s. |
| Moderate high PsyCap ➛ Low PsyCap | 0.00* | 0.00* | <0.05 |
| Moderate high PsyCap ➛ Dominant efficacy PsyCap | 0.00 | 0.00 | n.s. |
| Moderate high PsyCap ➛ Dominant hope PsyCap | 0.00 | 0.00 | n.s. |
| Moderate high PsyCap (no transition) | 1.00* | 1.00** | n.s. |
| Moderate high PsyCap ➛ High PsyCap | 0.00 | 0.00 | n.s. |
| High PsyCap ➛ Low PsyCap | 0.39* | 0.09 | <0.05 |
| High PsyCap ➛ Dominant efficacy PsyCap | 0.07 | 0.02 | n.s. |
| High PsyCap ➛ Dominant hope PsyCap | 0.00 | 0.00 | n.s. |
| High PsyCap ➛ Moderate high PsyCap | 0.00 | 0.00 | n.s. |
| High PsyCap (no transition) | 0.54* | 0.89** | <0.05 |
LMX, leader-member exchange.
*p < 0.05; **p < 0.001.